Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, today announced the appointment of Frederick C. Beddingfield III, M.D., Ph.D., as Chief Executive Officer and board director.

https://www.businesswire.com/news/home/20241111308275/en/Rubedo-Life-Sciences-Appoints-Former-Allergan-Executive-and-Biotechnology-Veteran-Dr.-Frederick-Beddingfield-III-as-CEO